Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.

Kikuchi T, Kondo U, Sugita S, Watanabe M, Matsumoto C, Nomura-Yogo M, Kunisada K, Sato K, Takei T, Abe Y, Hosoya O, Ishida T, Tsukada N

Open source

DOI: 10.1111/bjh.70602
Published: 2026 Aug
Container: British journal of haematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70602,
  title = {Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.},
  author = {Kikuchi T and Kondo U and Sugita S and Watanabe M and Matsumoto C and Nomura-Yogo M and Kunisada K and Sato K and Takei T and Abe Y and Hosoya O and Ishida T and Tsukada N},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70602},
  url = {https://doi.org/10.1111/bjh.70602}
}

RIS

TY  - JOUR
TI  - Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.
AU  - Kikuchi T
AU  - Kondo U
AU  - Sugita S
AU  - Watanabe M
AU  - Matsumoto C
AU  - Nomura-Yogo M
AU  - Kunisada K
AU  - Sato K
AU  - Takei T
AU  - Abe Y
AU  - Hosoya O
AU  - Ishida T
AU  - Tsukada N
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70602
UR  - https://doi.org/10.1111/bjh.70602
ER  -

APA

T, K., U, K., S, S., M, W., C, M., M, N., K, K., K, S., T, T., Y, A., O, H., T, I., & N, T. (2026). Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.. British journal of haematology. https://doi.org/10.1111/bjh.70602

Source records

pubmed · retrieved 2026-09-26T14:03:55.516Z